Pharmaceutical
 Formulation Portfolio

For new product approvals and first-time orders, the complete process—from artwork approval to final dispatch—takes 40 to 45 days. This includes DCGI clearance, cylinder engraving, and packaging material printing. For repeat orders of the exact same formulation, the manufacturing and delivery timeline is significantly reduced to 25 to 30 days.

We maintain strict WHO-GMP compliance and provide a comprehensive documentation packet with every dispatch. This packet includes the Certificate of Analysis (COA) for the finished product, Form 39, detailed raw material testing reports, Batch Manufacturing Records (BMR) references, and standard GST tax invoices, ensuring 100% compliance for domestic Indian distribution.

Yes, 100% of the formulations manufactured at Saar Biotech are approved by the Drug Controller General of India (DCGI) and the State FDA. We strictly manufacture within approved therapeutic monographs and maintain updated manufacturing licenses for over 200+ active molecules across various therapeutic segments.

We specialize in high-quality packaging for liquid and specialized formulations. We offer amber and PET bottles with precision measuring caps in 30ml, 60ml, 100ml, and 200ml variants for syrups and suspensions, complete with premium drip-off or UV mono-carton printing. For drops and dry syrups, we provide customized, spill-proof and moisture-resistant packaging solutions.

For domestic B2B contract manufacturing, our standard commercial terms require a 25% to 30% advance payment upon order confirmation and artwork approval. The remaining 70% to 75% balance is payable against the proforma invoice strictly prior to the final dispatch of the material from our Baddi facility.

Yes, Saar Biotech operates a state-of-the-art facility in Baddi, Himachal Pradesh that is fully WHO-GMP and ISO 9001:2015 certified. We undergo rigorous periodic audits by domestic regulatory bodies to ensure zero-defect manufacturing standards across our dedicated Beta-Lactam and Non-Beta Lactam blocks.

Absolutely. We have an in-house design and regulatory team that assists partners with complete artwork creation, color matching, and label text compliance as per Schedule V of the Drugs and Cosmetics Act. Artwork approval typically takes 3 to 5 business days before we initiate the final cylinder engraving process.

We procure Active Pharmaceutical Ingredients (APIs) and excipients exclusively from WHO-GMP approved vendors. Every raw material batch undergoes a strict 3-stage QA protocol—initial sampling, rigorous chemical/microbiological testing in our GLP-certified labs, and final QA release—before it enters the manufacturing floor.

While our standard MOQs are designed for optimal commercial pricing, we do accommodate smaller pilot batches for niche molecules or new brand launches. Depending on the API cost and machine scheduling, trial batch sizes can occasionally be approved for quantities 20% to 30% lower than standard MOQs. Please consult our commercial team for specific molecule approvals.